Press Resease

Molecular Cytogenetics Market: by Product (instruments, consumables and software & services), Technique (Genomic In Situ Hybridization (GISH), Fluorescence In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Multicolor Fluorescence In Situ Hybridization, Array Comparative Genomic Hybridization and Other Molecular Cytogenetic Techniques), Application (Genetic Disorders, Oncology, Personalized Medicine and Other Applications), End user (Clinical & Research Laboratories, Hospitals & Pathology Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies and Other End-user) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Published Date: 24-Oct-2019 Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-4926 Status : Published

Description

The report covers forecast and analysis for the Molecular Cytogenetics market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Molecular Cytogenetics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Molecular Cytogenetics market on a global level. In order to give the users of this report a comprehensive view on the Molecular Cytogenetics market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product, technique, application, end-user, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

Molecular Cytogenetics consists of cytogenetics and molecular biology. Cytogenetics refers to the study of chromosomes and further includes the examination of genetic variations or modifications by techniques of in-situ hybridization. In the field of biology and medicine, Molecular Cytogenetics consider essential applications. The genetic variation through in-situ hybridization techniques is Molecular Cytogenetics. It provides a high-resolution analysis of genome organization, behavior, and structure. Due to the increasing incidence of cancer and genetic disorders and the accelerating penetration of Molecular Cytogenetics in clinical pathological research, the global Molecular Cytogenetics market is growing at a significant rate. Various products such as kits & reagents, consumables, devices, and technology & services have contributed to the size of the market for Molecular Cytogenetics.

The study provides a decisive view on the Molecular Cytogenetics market by segmenting the market based on treatment product, application, technique, end user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on product, the market is segmented into instruments, consumables and software & services. The expanded use of media and reagents during cytogenetic research has made consumables the largest category. Consumables help to achieve consistent and reproducible results in both standard and advanced cytogenetic clinical protocols.

Based on technique, the market is segmented into Genomic In Situ Hybridization (GISH), Fluorescence In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Multicolor Fluorescence In Situ Hybridization, Array Comparative Genomic Hybridization and Other Molecular Cytogenetic Techniques. CGH and FISH techniques are widely adopted in the current scenario through various applications such as diagnostics, research practices, and the development of medicine.

Based on application, the market is segmented into Genetic Disorders, Oncology, Personalized Medicine and Other Applications. For in-depth cancer studies, successful and high use of molecular cytogenetic techniques has allowed oncology to emerge as the largest application category.

Based on end-user, the market is segmented into Clinical & Research Laboratories, Hospitals & Pathology Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies and Other End-user. In 2018, the market dominated by Clinical & Research Laboratories. This is primarily due to the increasing use in clinical diagnosis of cytogenetic techniques. Continuous research on the mechanisms underlying various chromosomal diseases has allowed it segment to gain the largest share.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries such as US, Canada, Germany, UK, France, China, Japan, India, GCC countries, Brazil. North America accounted for the largest share in 2018 mainly due to the local presence of major entities. Moreover, presence of effective regulatory framework for the regulation of genetic tests has significantly propelled the regional market.

Increasing cancer incidence and related annual mortality increase has pushed the market significantly. Continued increase in new cases of cancer has highlighted the need for advanced technology advancement for a detailed genomic level understanding of cancer. FISH and Comparative Genomic Hybridization (CGH) are among the most widely recognized cytogenetic techniques as they provide comprehensive information on molecular signatures associated with cancer. These techniques help to gain insight into the progression of cancer. Lack of consistent policies for coverage and reimbursement of new genomic tools can impede the use of Molecular Cytogenetics in cancer and personalized care. In addition, the shortage of qualified staff and high costs associated with the installation and handling of advanced techniques are likely to hamper the market in the future.

Key players within global Molecular Cytogenetics market include ARUP Laboratories, Calgary Laboratory Services, Genesis Laboratories Inc., Integrated Systems Engineering S.r.l., Neogenomics, OHSU School of Medicine-Molecular and Medical Genetics, South West Thames Regional Genetics Service, UCLA Health - UCLA Pathology and Laboratory Medicines, UW Cytogenetic Services, Virtual Scientific, Weill Cornell Medicine and WiCell Research Institute, Inc. amongst others.

The report segments global Molecular Cytogenetics market as follows:

Global Molecular Cytogenetics Market: Product Segment Analysis

  • Instruments
  • Consumables
  • Software & Services

Global Molecular Cytogenetics Market: Technique Segment Analysis

  • Genomic In Situ Hybridization (GISH)
  • Fluorescence In Situ Hybridization (FISH)
  • Comparative Genomic Hybridization (CGH)
  • Multicolor Fluorescence In Situ Hybridization
  • Array Comparative Genomic Hybridization
  • Other Molecular Cytogenetic Techniques

Global Molecular Cytogenetics Market: Application Segment Analysis

  • Genetic Disorders
  • Oncology
  • Personalized Medicine
  • Other Applications

Global Molecular Cytogenetics Market: End-user Segment Analysis

  • Clinical & Research Laboratories
  • Hospitals & Pathology Laboratories
  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End-user

Global Molecular Cytogenetics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Molecular Cytogenetics Market, 2016-2025 (USD Million)
    • 2.2. Molecular Cytogenetics Market: Snapshot
  • Chapter 3. Molecular Cytogenetics Market - Industry Analysis
    • 3.1. Molecular Cytogenetics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness analysis By Technique
      • 3.6.3. Market attractiveness analysis By Application
      • 3.6.4. Market attractiveness analysis By End-user
      • 3.6.5. Market attractiveness analysis by Region
  • Chapter 4. Molecular Cytogenetics Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Molecular Cytogenetics Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Molecular Cytogenetics Market -Product Analysis
    • 5.1. Global Molecular Cytogenetics Market overview: By Product type
      • 5.1.1. Global Molecular Cytogenetics Market share, By Product,2018 and 2025
    • 5.2. Instruments
      • 5.2.1. Global Molecular Cytogenetics Market by Instruments, 2016-2025 (USD Million)
    • 5.3. Consumables
      • 5.3.1. Global Molecular Cytogenetics Market by Consumables, 2016-2025 (USD Million)
    • 5.4. Software & Services
      • 5.4.1. Global Molecular Cytogenetics Market by Software & Services, 2016-2025 (USD Million)
  • Chapter 6. Global Molecular Cytogenetics Market -Technique Analysis
    • 6.1. Global Molecular Cytogenetics Market overview: By Technique
      • 6.1.1. Global Molecular Cytogenetics Market share, By Technique, 2018 and 2025
    • 6.2. Genomic In Situ Hybridization (GISH)
      • 6.2.1. Global Molecular Cytogenetics Market By Genomic In Situ Hybridization (GISH), 2016-2025 (USD Million)
    • 6.3. Fluorescence In Situ Hybridization (FISH)
      • 6.3.1. Global Molecular Cytogenetics Market By Fluorescence In Situ Hybridization (FISH), 2016-2025 (USD Million)
    • 6.4. Comparative Genomic Hybridization (CGH)
      • 6.4.1. Global Molecular Cytogenetics Market By Comparative Genomic Hybridization (CGH), 2016-2025 (USD Million)
    • 6.5. Multicolor Fluorescence In Situ Hybridization
      • 6.5.1. Global Molecular Cytogenetics Market By Multicolor Fluorescence In Situ Hybridization, 2016-2025 (USD Million)
    • 6.6. Array Comparative Genomic Hybridization
      • 6.6.1. Global Molecular Cytogenetics Market by Array Comparative Genomic Hybridization, 2016-2025 (USD Million)
    • 6.7. Other Molecular Cytogenetic Techniques
      • 6.7.1. Global Molecular Cytogenetics Market by Other Molecular Cytogenetic Techniques, 2016-2025 (USD Million)
  • Chapter 7. Global Molecular Cytogenetics Market -Application Analysis
    • 7.1. Global Molecular Cytogenetics Market overview: By Application
      • 7.1.1. Global Molecular Cytogenetics Market share, By Application, 2018 and 2025
    • 7.2. Genetic Disorders
      • 7.2.1. Global Molecular Cytogenetics Market by Genetic Disorders, 2016-2025 (USD Million)
    • 7.3. Oncology
      • 7.3.1. Global Molecular Cytogenetics Market by Oncology, 2016-2025 (USD Million)
    • 7.4. Personalized Medicine
      • 7.4.1. Global Molecular Cytogenetics Market by Personalized Medicine, 2016-2025 (USD Million)
    • 7.5. Others
      • 7.5.1. Global Molecular Cytogenetics Market by Application others, 2016-2025 (USD Million)
  • Chapter 8. Global Molecular Cytogenetics Market - End-user Analysis
    • 8.1. Global Molecular Cytogenetics Market overview: By End-user
      • 8.1.1. Global Molecular Cytogenetics Market share, By End-user, 2018 and 2025
    • 8.2. Clinical & Research Laboratories
      • 8.2.1. Global Molecular Cytogenetics Market by Clinical & Research Laboratories, 2016-2025 (USD Million)
    • 8.3. Hospitals & Pathology Laboratories
      • 8.3.1. Global Molecular Cytogenetics Market by Hospitals & Pathology Laboratories, 2016-2025 (USD Million)
    • 8.4. Academic Research Institutes
      • 8.4.1. Global Molecular Cytogenetics Market by Academic Research Institutes, 2016-2025 (USD Million)
    • 8.5. Pharmaceutical and Biotechnology Companies
      • 8.5.1. Global Molecular Cytogenetics Market by Pharmaceutical and Biotechnology Companies, 2016-2025 (USD Million)
    • 8.6. Others
      • 8.6.1. Global Molecular Cytogenetics Market by End-user Others, 2016-2025 (USD Million)
  • Chapter 9. Global Molecular Cytogenetics Market - Regional Analysis
    • 9.1. Global Molecular Cytogenetics Market overview: by Region
      • 9.1.1. Global Molecular Cytogenetics Marketshare, by Region, 2018 and 2025
    • 9.2. North America
      • 9.2.1. North America Molecular Cytogenetics Market, 2016-2025 (USD Million)
      • 9.2.2. North America Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
      • 9.2.3. North America Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
      • 9.2.4. North America Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
      • 9.2.5. North America Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.2.6. The U.S.
        • 9.2.6.1. The U.S.Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.2.6.2. The U.S.Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.2.6.3. The U.S.Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.2.6.4. The U.S.Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.2.7. Rest of North America
        • 9.2.7.1. Rest of North America Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.2.7.2. Rest of North America Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.2.7.3. Rest of North America Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.2.7.4. Rest of North America Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
    • 9.3. Europe
      • 9.3.1. Europe Molecular Cytogenetics Market, 2016-2025 (USD Million)
      • 9.3.2. Europe Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
      • 9.3.3. Europe Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
      • 9.3.4. Europe Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
      • 9.3.5. Europe Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.3.6. UK
        • 9.3.6.1. U.K.Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.3.6.2. U.K.Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.3.6.3. U.K. Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.3.6.4. U.K. Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.3.7. France
        • 9.3.7.1. France Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.3.7.2. France Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.3.7.3. France Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.3.7.4. France Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.3.8. Germany
        • 9.3.8.1. Germany Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.3.8.2. Germany Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.3.8.3. Germany Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.3.8.4. Germany Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.3.9. Rest of Europe
        • 9.3.9.1. Rest of EuropeMolecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.3.9.2. Rest of EuropeMolecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.3.9.3. Rest of Europe Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.3.9.4. Rest of Europe Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific Molecular Cytogenetics Market, 2016-2025 (USD Million)
      • 9.4.2. Asia Pacific Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
      • 9.4.3. Asia Pacific Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
      • 9.4.4. Asia Pacific Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
      • 9.4.5. Asia Pacific Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.4.6. China
        • 9.4.6.1. China Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.4.6.2. China Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.4.6.3. China Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.4.6.4. China Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million
      • 9.4.7. Japan
        • 9.4.7.1. Japan Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.4.7.2. Japan Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.4.7.3. Japan Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.4.7.4. Japan Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.4.8. India
        • 9.4.8.1. India Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.4.8.2. India Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.4.8.3. India Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.4.8.4. India Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.4.9.2. Rest of Asia Pacific Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.4.9.3. Rest of Asia Pacific Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.4.9.4. Rest of Asia Pacific Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
    • 9.5. Latin America
      • 9.5.1. Latin America Molecular Cytogenetics Market, 2016-2025 (USD Million)
      • 9.5.2. Latin America Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
      • 9.5.3. Latin America Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
      • 9.5.4. Latin America Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
      • 9.5.5. Latin America Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.5.6.2. Brazil Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.5.6.3. Brazil Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.5.6.4. Brazil Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
      • 9.5.7. Rest of LatinAmerica
        • 9.5.7.1. Rest of LatinAmerica Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
        • 9.5.7.2. Rest of LatinAmerica Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
        • 9.5.7.3. Rest of Latin America Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
        • 9.5.7.4. Rest of Latin America Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa Molecular Cytogenetics Market, 2016-2025 (USD Million)
      • 9.6.2. The Middle East and Africa Molecular Cytogenetics Market revenue, By Product,2016-2025 (USD Million)
      • 9.6.3. The Middle East and Africa Molecular Cytogenetics Market revenue, By Technique, 2016-2025 (USD Million)
      • 9.6.4. The Middle East and Africa Molecular Cytogenetics Market revenue, By Application, 2016-2025 (USD Million)
      • 9.6.5. The Middle East and Africa Molecular Cytogenetics Market revenue, By End-user, 2016-2025 (USD Million)
  • Chapter 10. Company Profiles
    • 10.1. ARUP Laboratories
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. Calgary Laboratory Services
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. Genesis Laboratories Inc.
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. Integrated Systems Engineering S.r.l
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. Neogenomics
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Development
    • 10.6. OHSU School of Medicine-Molecular and Medical Genetics
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Development
    • 10.7. South West Thames Regional Genetics Service
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Development
    • 10.8. UCLA Health - UCLA Pathology and Laboratory Medicines
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Development
    • 10.9. UW Cytogenetic Services
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business Strategy
      • 10.9.5. Recent Development
    • 10.10. Virtual Scientific
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business Strategy
      • 10.10.5. Recent Development

Methodology

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com